Leukaemia (chronic lymphocytic, first line) - rituximab: Appendix A - provisional matrix of stakeholders

Leukaemia (chronic lymphocytic, first line) - rituximab: Appendix A - provisional matrix of stakeholders

Leukaemia (chronic lymphocytic, first line) - rituximab: Appendix A - provisional matrix of stakeholders
20 January 2014
(100.52 Kb 29 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 14 January 2014